Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
SVRA - Savara, Inc.
Market Cap 477.26M P/E - EPS this Y -18.20% Ern Qtrly Grth -
Income -54.7M Forward P/E -12.61 EPS next Y 12.80% 50D Avg Chg 16.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 64.00%
Dividend N/A Price/Book 4.10 EPS next 5Y - 52W High Chg -8.00%
Recommedations 1.60 Quick Ratio 15.44 Shares Outstanding 138.18M 52W Low Chg 227.00%
Insider Own 5.63% ROA -23.32% Shares Float 81.34M Beta 0.70
Inst Own 84.40% ROE -44.09% Shares Shorted/Prior 3.35M/3.40M Price 3.53
Gross Margin - Profit Margin - Avg. Volume 632,946 Target Price 8.79
Oper. Margin - Earnings Date May 13 Volume 418,792 Change -1.12%
Healthcare | Biotechnology | United States
About Savara, Inc.

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.

Savara, Inc. News
05/07/24 Savara to Present at the Citizens JMP Life Sciences Conference
07:05 AM Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
03/22/24 Savara Announces New Employment Inducement Grant
03/07/24 Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update
03/06/24 Savara to Present at the Barclays 26th Annual Global Healthcare Conference
02/20/24 Savara Inc. (NASDAQ:SVRA): Are Analysts Optimistic?
01/31/24 Savara to Present at Two Upcoming Healthcare Conferences
12/30/23 Insider Sell: CEO Matthew Pauls Disposes of 84,000 Shares of Savara Inc (SVRA)
12/21/23 Savara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
12/20/23 Savara Added to the NASDAQ Biotechnology Index
12/01/23 Savara Inc. (NASDAQ:SVRA) most popular amongst private equity firms who own 41% of the shares, institutions hold 31%
11/21/23 Savara to Present at the Piper Sandler 35th Annual Healthcare Conference
11/09/23 Savara Reports Third Quarter Financial Results and Provides Business Update
04:05 PM Savara to Present at the Jefferies London Healthcare Conference
11/04/23 Bullish Savara Insiders Loaded Up On US$611.8k Of Stock
09/27/23 3 Penny Stocks to Provide 1,000% Returns Over the Next Decade
09/17/23 15 Penny Stocks with Biggest Upside
09/12/23 The 3 Best Penny Stocks to Buy Now: September 2023
09/11/23 Savara Inc.'s (NASDAQ:SVRA) Path To Profitability
09/05/23 Savara to Present at the H.C. Wainwright 25th Annual Global Investment Conference
SVRA Chatroom

User Image Danboo Posted - 17 hours ago

$SVRA It’s starting. Medinfo

User Image Doorkey Posted - 18 hours ago

$SVRA $0.10 off....

User Image Doorkey Posted - 18 hours ago

$SVRA Another good $$$$$ day.

User Image Doorkey Posted - 20 hours ago

$SVRA $5.40 EOD

User Image Doorkey Posted - 4 days ago

$RZLT $SVRA Both are $8 June swings.

User Image StockInvest_us Posted - 6 days ago

Signal alert: $SVRA - PivotPoint bottom https://stockinvest.us/l/L0d3ZsTPLt

User Image DougieFreshPicks Posted - 6 days ago

$SVRA I have no idea what this company does besides it is in biotech and healthcare. Chart still looks good and I am holding for longer!!!

User Image TKtoCk Posted - 6 days ago

$SVRA 8.00 easy!!!

User Image Doorkey Posted - 6 days ago

$SVRA $$$$$$ new shade of green.

User Image chrishoov Posted - 6 days ago

$SVRA nice move…

User Image Aigner_Andreas Posted - 04/29/24

TD BUY $SVRA at 4.61, Supp 4.24 Resis 5.34 R26 HiLo 74% T1Y 4 buy 1.6 DIV N/A #Savara Inc #stocks #trading #finance #market

User Image Zeffanator Posted - 04/29/24

$SVRA Someone’s loading after hours. See what tomorrow brings.

User Image MarketMasterMind Posted - 04/26/24

$SVRA load up, huge runner incoming 🤑Ⓜ️

User Image Capes Posted - 04/25/24

$CRKN $HOLO $PEGY $SVRA $FRGT

User Image Doorkey Posted - 04/25/24

$SVRA Good vibes, another AH price jump.

User Image TKtoCk Posted - 04/25/24

$SVRA what’s going on that we don’t know about??

User Image Flydown Posted - 04/25/24

$SVRA what's happened!

User Image Richterscale Posted - 04/24/24

$SVRA Ouch? What gives?

User Image Doorkey Posted - 04/23/24

$SVRA Summer come early? AH jump after huge buy?

User Image Doorkey Posted - 04/17/24

$SVRA Summer showers of $$$$$$$$$$$

User Image dago1 Posted - 04/17/24

$SVRA IF U LIKE TO MAKE EASY 💰 🤑, SWITCH TO SINT, 😆

User Image Doorkey Posted - 04/17/24

$SVRA $LYRA Bullish cuz I'm green.

User Image PLATINUM_TRADES Posted - 04/16/24

$SVRA what a dumbass I am.... Wasn't patient enough.. But.....

User Image PLATINUM_TRADES Posted - 04/15/24

$SVRA I took the loss on this one.. Only the second loss all month... I'm OK with that I always make up my losses.. Even bigger 👍🏻👍🏻

User Image Stocksrunner Posted - 04/12/24

📉 | Friday Roundup: $ANET may not be a big AI winner, analyst warns in downgrade to Sell. $SPIR Sees IPO of 8.89m Shares at $4.50 a Share. $SVRA Announces Proposed IPO. $TCS rating maintained by Jefferies after earnings. $UCG investors back new term for Orcel, support pay rise.

User Image UpTick_ Posted - 04/12/24

$SVRA 13D Bain Capital Life Sciences Fund II, L.P. Shared voting power 14,565,457 shares of Common Stock Percent of class represented by amount in Row (11) 9.99% https://fintel.io/doc/sec-bain-capital-life-sciences-fund-ii-lp-1160308-sc-13da-2024-april-12-19825-9289

User Image PLATINUM_TRADES Posted - 04/12/24

$SVRA add! Love the dips

User Image PLATINUM_TRADES Posted - 04/12/24

$SVRA adds!

User Image PLATINUM_TRADES Posted - 04/11/24

$SVRA awesome day and we keeping it... This should make a move towards $6.00 imo on this beautiful break today 🥊🥊🥊🥊

User Image Jaybooggy Posted - 04/11/24

$SVRA this should be a nice swing

Analyst Ratings
JMP Securities Market Outperform May 6, 24
JMP Securities Market Outperform Apr 19, 24
JMP Securities Market Outperform Apr 18, 24
HC Wainwright & Co. Buy Mar 11, 24
Piper Sandler Overweight Mar 4, 24
JMP Securities Market Outperform Feb 15, 24
HC Wainwright & Co. Buy Nov 13, 23
Guggenheim Buy Nov 7, 23
HC Wainwright & Co. Buy Aug 14, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Pauls Matthew CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Dec 28 Sell 4.71 84,000 395,640 1,302,674 12/29/23
Lowrance David L CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Dec 28 Sell 4.7131 10,000 47,131 342,355 12/29/23
Elam Nevan C Director Director Dec 28 Sell 4.71 93,843 442,001 22,500 12/29/23
Elam Nevan C Director Director Dec 28 Option 1.21 53,758 65,047 116,343 12/29/23
Hawkins Richard J Director Director Dec 11 Option 0.82 10,841 8,890 12,741 12/12/23
Elam Nevan C Director Director Dec 11 Option 0.82 10,841 8,890 40,085 12/12/23
Yang Rick 10% Owner 10% Owner Jul 17 Buy 3.00 333,333 999,999 24,471,264 07/19/23
Walker Paul Edward 10% Owner 10% Owner Jul 17 Buy 3.00 333,333 999,999 24,471,264 07/19/23
SANDELL SCOTT D 10% Owner 10% Owner Jul 17 Buy 3.00 333,333 999,999 24,471,264 07/19/23
Mathers Edward T 10% Owner 10% Owner Jul 17 Buy 3.00 333,333 999,999 24,471,264 07/19/23
Makhzoumi Mohamad 10% Owner 10% Owner Jul 17 Buy 3.00 333,333 999,999 24,471,264 07/19/23
Florence Anthony A. Jr. 10% Owner 10% Owner Jul 17 Buy 3.00 333,333 999,999 24,471,264 07/19/23
Chang Carmen 10% Owner 10% Owner Jul 17 Buy 3.00 333,333 999,999 24,471,264 07/19/23
Behbahani Ali 10% Owner 10% Owner Jul 17 Buy 3.00 333,333 999,999 24,471,264 07/19/23
BASKETT FOREST 10% Owner 10% Owner Jul 17 Buy 3.00 333,333 999,999 24,471,264 07/19/23
Growth Equity Opportunities 17... 10% Owner 10% Owner Jul 17 Buy 3.00 333,333 999,999 24,471,264 07/19/23
Pratt Raymond Dennis Chief Medical Office.. Chief Medical Officer Jun 26 Buy 2.93 6,500 19,045 160,000 06/27/23
RAMSAY DAVID A Director Director May 24 Buy 2.59 100,000 259,000 2,201,142 05/26/23
RAMSAY DAVID A Director Director Dec 23 Buy 1.47 19,000 27,930 2,065,142 12/28/22
Pratt Raymond Dennis Chief Medical Office.. Chief Medical Officer Dec 22 Buy 1.5434 3,500 5,402 153,500 12/22/22
RAMSAY DAVID A Director Director Dec 20 Buy 1.48 45,000 66,600 2,046,142 12/22/22
Hawkins Richard J Director Director Dec 07 Option 0.65 1,172 762 1,900 12/08/22
RAMSAY DAVID A Director Director Sep 23 Buy 1.39 135,000 187,650 1,876,142 09/27/22
RAMSAY DAVID A Director Director Sep 06 Buy 1.39 32,000 44,480 1,733,142 09/08/22
RAMSAY DAVID A Director Director Jun 17 Buy 1.38 100,000 138,000 1,601,142 06/22/22
RAMSAY DAVID A Director Director Aug 19 Buy 1.19 97,290 115,775 964,090 08/19/21
Chowdhury Badrul A. CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER May 17 Option 0 200,000 200,000 05/17/21
Chowdhury Badrul A. CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER May 17 Sell 1.56 50,000 78,000 150,000 05/17/21